RetractedArticleEvidence-based complementary and alternative medicine : eCAM2022

Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo.

Yuzhen Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.